(20S)-ginsenoside Rg3 multiple interactions ISO RGD:11315 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl 54% Chlorine results in decreased expression of SLC6A3 protein] CTD PMID:24394491 (R)-noradrenaline multiple interactions ISO RGD:733809 6480464 SLC6A3 protein promotes the reaction [Norepinephrine results in increased activity of TAAR1 protein] CTD PMID:17234900 (R)-noradrenaline increases uptake ISO RGD:733809 6480464 SLC6A3 protein results in increased uptake of Norepinephrine CTD PMID:17250655 (R)-octopamine multiple interactions ISO RGD:733809 6480464 indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 (S)-amphetamine increases activity ISO RGD:11315 6480464 Dextroamphetamine results in increased activity of SLC6A3 protein CTD PMID:12716422 (S)-amphetamine multiple interactions ISO RGD:733809 6480464 Dextroamphetamine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:30776375 (S)-amphetamine multiple interactions EXP 6480464 Dextroamphetamine inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:24841869 (S)-amphetamine decreases activity ISO RGD:733809 6480464 Dextroamphetamine results in decreased activity of SLC6A3 protein CTD PMID:30776375 (S)-amphetamine decreases expression EXP 6480464 Dextroamphetamine results in decreased expression of SLC6A3 protein CTD PMID:15900317 (S)-amphetamine multiple interactions ISO RGD:11315 6480464 1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine inhibits the reaction [Dextroamphetamine results in increased activity of SLC6A3 protein] CTD PMID:12716422 (S)-amphetamine affects response to substance ISO RGD:11315 6480464 SLC6A3 protein affects the susceptibility to Dextroamphetamine CTD PMID:11797063 (S)-nicotine multiple interactions EXP 6480464 Dihydro-beta-Erythroidine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein], Mecamylamine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein] CTD PMID:23999947 (S)-nicotine increases methylation ISO RGD:11315 6480464 Nicotine results in increased methylation of SLC6A3 promoter CTD PMID:31945395 (S)-nicotine decreases expression ISO RGD:11315 6480464 Nicotine results in decreased expression of SLC6A3 mRNA, Nicotine results in decreased expression of SLC6A3 protein CTD PMID:31945395 (S)-nicotine multiple interactions ISO RGD:11315 6480464 Nicotine inhibits the reaction [Paraquat results in decreased expression of SLC6A3 protein] CTD PMID:17227438 (S)-nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of SLC6A3 protein CTD PMID:23999947 1,2-dimethylhydrazine decreases expression ISO RGD:11315 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC6A3 mRNA CTD PMID:22206623 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine affects binding ISO RGD:11315 6480464 1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine binds to SLC6A3 protein CTD PMID:11226678 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine affects binding EXP 6480464 1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine binds to SLC6A3 protein CTD PMID:15985715 more ... 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine multiple interactions EXP 6480464 Paraquat inhibits the reaction [1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine binds to SLC6A3 protein] CTD PMID:15985715 more ... 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine multiple interactions ISO RGD:11315 6480464 1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine inhibits the reaction [Dextroamphetamine results in increased activity of SLC6A3 protein], NR3C1 protein inhibits the reaction [1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine binds to SLC6A3 protein] CTD PMID:11226678 , PMID:12716422 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO RGD:11315 6480464 SLC6A3 mutant form promotes the reaction [Citalopram results in increased abundance of Dopamine] CTD PMID:14691264 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile affects response to substance ISO RGD:733809 6480464 SLC6A3 protein polymorphism affects the susceptibility to Citalopram CTD PMID:31009648 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile multiple interactions ISO RGD:733809 6480464 [SLC6A3 protein polymorphism affects the susceptibility to Citalopram] which affects the uptake of Dopamine, Citalopram inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:31009648 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO RGD:11315 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:11315 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:30195017 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases activity ISO RGD:11315 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:11315 6480464 1 more ... CTD PMID:16011487 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] inhibits the reaction [SLC6A3 protein affects the export of Dopamine] more ... CTD PMID:16451217 , PMID:19479021 17beta-estradiol multiple interactions ISO RGD:733809 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of SLC6A3 mRNA CTD PMID:20404318 17beta-estradiol multiple interactions ISO RGD:11315 6480464 Estradiol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC6A3 protein CTD PMID:16451217 17beta-estradiol 3-benzoate multiple interactions ISO RGD:11315 6480464 estradiol 3-benzoate inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 mRNA], estradiol 3-benzoate inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] CTD PMID:15249736 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:26215117 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A3 mRNA CTD PMID:32109520 2,5-dimethoxy-4-bromophenethylamine multiple interactions ISO RGD:733809 6480464 2-4-bromo-2 more ... CTD PMID:28506818 2-aminopropiophenone decreases expression ISO RGD:11315 6480464 cathinone analog results in decreased expression of SLC6A3 mRNA CTD PMID:28173643 2-phenylethylamine multiple interactions ISO RGD:733809 6480464 Cocaine inhibits the reaction [SLC6A3 protein results in increased transport of phenethylamine], SLC6A3 protein promotes the reaction [phenethylamine results in increased activity of TAAR1 protein] CTD PMID:15764732 , PMID:17234900 2-phenylethylamine increases transport ISO RGD:733809 6480464 SLC6A3 protein results in increased transport of phenethylamine CTD PMID:15764732 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:733809 6480464 N-Methyl-3 more ... CTD PMID:28506818 more ... 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO RGD:733809 6480464 bisindolylmaleimide I inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein] CTD PMID:12112414 4,4'-sulfonyldiphenol increases expression ISO RGD:11315 6480464 bis4-hydroxyphenylsulfone results in increased expression of SLC6A3 mRNA CTD PMID:30951980 4-nitrotoluene decreases expression EXP 6480464 4-nitrotoluene results in decreased expression of SLC6A3 mRNA CTD PMID:15265578 7-NITROINDAZOLE multiple interactions ISO RGD:11315 6480464 7-nitroindazole inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] CTD PMID:20575850 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLC6A3, Acrylamide results in decreased expression of SLC6A3 mRNA CTD PMID:25943760 , PMID:28959563 albiflorin affects expression EXP 6480464 albiflorin affects the expression of SLC6A3 CTD PMID:26475043 alcohol increases activity ISO RGD:11315 6480464 Alcohols results in increased activity of SLC6A3 protein CTD PMID:11165777 alcohol multiple interactions ISO RGD:11315 6480464 [Alcohols co-treated with Cocaine] results in increased activity of SLC6A3 protein more ... CTD PMID:11165777 all-trans-retinoic acid multiple interactions ISO RGD:733809 6480464 [Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SLC6A3 protein CTD PMID:24101030 alpha,alpha-trehalose multiple interactions ISO RGD:11315 6480464 Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:25064079 AM-251 multiple interactions EXP 6480464 AM 251 affects the reaction [3R-2 more ... CTD PMID:29113897 aminorex multiple interactions EXP 6480464 Aminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:24841869 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC6A3 mRNA CTD PMID:16483693 amphetamine multiple interactions ISO RGD:11315 6480464 SLC6A3 protein affects the reaction [Amphetamine results in increased expression of FOS protein] CTD PMID:12699766 amphetamine increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to Amphetamine CTD PMID:15602501 amphetamine affects response to substance ISO RGD:733809 6480464 SLC6A3 3' UTR polymorphism affects the susceptibility to Amphetamine CTD PMID:19462300 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of DAT mRNA CTD PMID:15183010 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SLC6A3 mRNA CTD PMID:16126238 amphetamine decreases expression ISO RGD:11315 6480464 Amphetamine results in decreased expression of SLC6A3 protein CTD PMID:11731100 amphetamine decreases response to substance ISO RGD:733809 6480464 SLC6A3 3' UTR polymorphism results in decreased susceptibility to Amphetamine CTD PMID:15602501 amphetamine affects localization ISO RGD:733809 6480464 Amphetamine affects the localization of SLC6A3 protein CTD PMID:16684900 amphetamine multiple interactions ISO RGD:733809 6480464 [Amphetamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA more ... CTD PMID:11731100 more ... Aroclor 1254 multiple interactions ISO RGD:11315 6480464 [Chlorodiphenyl 54% Chlorine co-treated with aroclor 1260] inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] more ... CTD PMID:16702228 , PMID:24394491 Aroclor 1254 decreases expression ISO RGD:11315 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of SLC6A3 protein CTD PMID:22094459 , PMID:24394491 Aroclor 1254 multiple interactions EXP 6480464 [aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl 54% Chlorine co-treated with aroclor 1260] results in decreased expression of SLC6A3 protein, [Chlorodiphenyl 54% Chlorine co-treated with aroclor 1242 co-treated with aroclor 1248] results in decreased expression of SLC6A3 mRNA CTD PMID:17324953 , PMID:29879404 arsenite(3-) decreases expression ISO RGD:11315 6480464 arsenite results in decreased expression of SLC6A3 mRNA, arsenite results in decreased expression of SLC6A3 protein CTD PMID:29982692 , PMID:33053406 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of SLC6A3 protein CTD PMID:29982692 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SLC6A3 mRNA, Atrazine results in decreased expression of SLC6A3 protein CTD PMID:23123945 , PMID:24863964 atrazine increases expression EXP 6480464 Atrazine results in increased expression of SLC6A3 mRNA CTD PMID:28341570 benzatropine multiple interactions ISO RGD:733809 6480464 Benztropine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:17250655 benzo[a]pyrene affects methylation ISO RGD:733809 6480464 Benzoapyrene affects the methylation of SLC6A3 3' UTR, Benzoapyrene affects the methylation of SLC6A3 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:733809 6480464 Benzoapyrene results in increased methylation of SLC6A3 5' UTR, Benzoapyrene results in increased methylation of SLC6A3 promoter CTD PMID:27901495 benzo[e]pyrene increases methylation ISO RGD:733809 6480464 benzoepyrene results in increased methylation of SLC6A3 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression ISO RGD:11315 6480464 Mustard Gas results in increased expression of SLC6A3 mRNA CTD PMID:15674844 bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of SLC6A3 protein CTD PMID:19479021 bisphenol A increases expression ISO RGD:11315 6480464 bisphenol A results in increased expression of SLC6A3 mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A3 mRNA CTD PMID:15079872 more ... bisphenol A increases expression ISO RGD:733809 6480464 bisphenol A results in increased expression of SLC6A3 protein CTD PMID:27494678 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] inhibits the reaction [SLC6A3 protein affects the export of Dopamine], bisphenol A affects the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 bisphenol F increases expression ISO RGD:11315 6480464 bisphenol F results in increased expression of SLC6A3 mRNA CTD PMID:30951980 bupropion multiple interactions ISO RGD:733809 6480464 [Bupropion co-treated with SLC6A3 protein] results in increased expression of FOS protein more ... CTD PMID:12112414 more ... bupropion affects response to substance ISO RGD:733809 6480464 SLC6A3 protein polymorphism affects the susceptibility to Bupropion CTD PMID:31009648 bupropion increases expression ISO RGD:733809 6480464 Bupropion results in increased expression of SLC6A3 protein CTD PMID:27555326 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of SLC6A3 mRNA CTD PMID:28743636 cadmium dichloride increases expression ISO RGD:733809 6480464 Cadmium Chloride results in increased expression of SLC6A3 mRNA CTD PMID:12160620 caffeine increases response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form results in increased susceptibility to Caffeine CTD PMID:11222668 caffeine affects response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism affects the susceptibility to Caffeine CTD PMID:24403155 calcitriol increases expression ISO RGD:733809 6480464 Calcitriol results in increased expression of SLC6A3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:733809 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC6A3 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:733809 6480464 Carbamazepine affects the expression of SLC6A3 mRNA CTD PMID:25979313 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of SLC6A3 mRNA CTD PMID:18812211 chlorpyrifos decreases expression ISO RGD:11315 6480464 Chlorpyrifos results in decreased expression of SLC6A3 mRNA CTD PMID:29156651 citalopram multiple interactions ISO RGD:11315 6480464 SLC6A3 mutant form promotes the reaction [Citalopram results in increased abundance of Dopamine] CTD PMID:14691264 citalopram multiple interactions ISO RGD:733809 6480464 [SLC6A3 protein polymorphism affects the susceptibility to Citalopram] which affects the uptake of Dopamine, Citalopram inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:31009648 citalopram affects response to substance ISO RGD:733809 6480464 SLC6A3 protein polymorphism affects the susceptibility to Citalopram CTD PMID:31009648 clozapine affects response to substance ISO RGD:733809 6480464 SLC6A3 5' UTR affects the susceptibility to Clozapine CTD PMID:20580759 cocaine multiple interactions ISO RGD:733809 6480464 [Cocaine co-treated with SLC6A3 protein] results in increased expression of FOS protein more ... CTD PMID:12064476 more ... cocaine affects response to substance ISO RGD:733809 6480464 SLC6A3 protein polymorphism affects the susceptibility to Cocaine CTD PMID:31009648 cocaine decreases response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form results in decreased susceptibility to Cocaine CTD PMID:22034972 cocaine decreases expression ISO RGD:733809 6480464 Cocaine results in decreased expression of SLC6A3 mRNA CTD PMID:10581411 more ... cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of SLC6A3 protein CTD PMID:16179556 cocaine multiple interactions EXP 6480464 Cocaine promotes the reaction [SLC6A3 protein affects the uptake of Dopamine] more ... CTD PMID:11249581 , PMID:20035724 cocaine affects expression EXP 6480464 Cocaine affects the expression of SLC6A3 mRNA, Cocaine affects the expression of SLC6A3 protein CTD PMID:11072100 , PMID:11249581 cocaine affects response to substance ISO RGD:11315 6480464 SLC6A3 mutant form affects the susceptibility to Cocaine, SLC6A3 protein affects the susceptibility to Cocaine CTD PMID:11312315 more ... cocaine increases activity ISO RGD:11315 6480464 Cocaine results in increased activity of SLC6A3 protein CTD PMID:11165777 cocaine multiple interactions ISO RGD:11315 6480464 [Alcohols co-treated with Cocaine] results in increased activity of SLC6A3 protein more ... CTD PMID:11165777 , PMID:14691264 cocaine increases response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism results in increased susceptibility to Cocaine CTD PMID:8825631 cocaine increases expression ISO RGD:733809 6480464 Cocaine results in increased expression of SLC6A3 protein CTD PMID:16110277 , PMID:18565692 cocaine affects binding ISO RGD:733809 6480464 Cocaine binds to SLC6A3 protein CTD PMID:9372557 crocidolite asbestos decreases methylation ISO RGD:733809 6480464 Asbestos, Crocidolite results in decreased methylation of SLC6A3 gene CTD PMID:29523930 curcumin multiple interactions ISO RGD:733809 6480464 Curcumin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 protein] CTD PMID:30463061 cyhalothrin decreases expression EXP 6480464 cyhalothrin results in decreased expression of SLC6A3 protein CTD PMID:28495607 DDD multiple interactions ISO RGD:11315 6480464 Dichlorodiphenyldichloroethane inhibits the reaction [DAT protein results in increased uptake of Dopamine] CTD PMID:18533268 DDE multiple interactions EXP 6480464 [Dichlorodiphenyl Dichloroethylene co-treated with Estradiol] promotes the reaction [SLC6A3 protein affects the export of Dopamine], Dichlorodiphenyl Dichloroethylene inhibits the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 DDE multiple interactions ISO RGD:11315 6480464 Dichlorodiphenyl Dichloroethylene inhibits the reaction [DAT protein results in increased uptake of Dopamine] CTD PMID:18533268 DDT multiple interactions ISO RGD:11315 6480464 DDT inhibits the reaction [DAT protein results in increased uptake of Dopamine] CTD PMID:18533268 dextran sulfate multiple interactions ISO RGD:11315 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A3 mRNA CTD PMID:29950665 diazinon affects expression EXP 6480464 Diazinon affects the expression of SLC6A3 mRNA CTD PMID:18812211 diazinon increases expression EXP 6480464 Diazinon results in increased expression of SLC6A3 mRNA CTD PMID:29108742 dieldrin decreases expression ISO RGD:11315 6480464 Dieldrin results in decreased expression of SLC6A3 protein CTD PMID:17291500 dieldrin multiple interactions EXP 6480464 Dieldrin inhibits the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of SLC6A3 mRNA, Dieldrin results in increased expression of SLC6A3 protein CTD PMID:11719704 , PMID:18812211 dieldrin increases expression ISO RGD:11315 6480464 Dieldrin results in increased expression of SLC6A3 mRNA, Dieldrin results in increased expression of SLC6A3 protein CTD PMID:16809432 diethyldithiocarbamic acid increases expression EXP 6480464 Ditiocarb results in increased expression of SLC6A3 protein CTD PMID:22874009 diethylstilbestrol multiple interactions EXP 6480464 Diethylstilbestrol affects the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 dihydro-beta-erythroidine multiple interactions EXP 6480464 Dihydro-beta-Erythroidine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein] CTD PMID:23999947 dopamine multiple interactions ISO RGD:733809 6480464 2-3-methoxyphenyl-2-ethylaminocyclohexanone inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] more ... CTD PMID:12112414 more ... dopamine affects uptake ISO RGD:733809 6480464 SLC6A3 protein polymorphism affects the uptake of Dopamine CTD PMID:31009648 dopamine increases import ISO RGD:733809 6480464 SLC6A3 protein results in increased import of Dopamine CTD PMID:27555326 dopamine decreases import ISO RGD:733809 6480464 SLC6A3 protein mutant form results in decreased import of Dopamine CTD PMID:27555326 dopamine increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to Dopamine CTD PMID:23313730 dopamine increases uptake ISO RGD:733809 6480464 SLC6A3 protein results in increased uptake of Dopamine CTD PMID:16005927 more ... dopamine affects localization ISO RGD:733809 6480464 Dopamine affects the localization of SLC6A3 protein CTD PMID:20875051 dopamine increases uptake ISO RGD:11315 6480464 DAT protein results in increased uptake of Dopamine CTD PMID:18533268 dopamine affects export EXP 6480464 SLC6A3 protein affects the export of Dopamine CTD PMID:19479021 dopamine multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] inhibits the reaction [SLC6A3 protein affects the export of Dopamine] more ... CTD PMID:17555897 more ... dopamine affects abundance ISO RGD:11315 6480464 SLC6A3 protein affects the abundance of Dopamine CTD PMID:18690110 dopamine multiple interactions ISO RGD:11315 6480464 [Chlorodiphenyl 54% Chlorine co-treated with aroclor 1260] inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] more ... CTD PMID:11165777 more ... dopamine increases transport ISO RGD:733809 6480464 SLC6A3 protein results in increased transport of Dopamine CTD PMID:11707631 dopamine increases export ISO RGD:733809 6480464 SLC6A3 protein mutant form results in increased export of Dopamine CTD PMID:18614672 elemental selenium increases activity EXP 6480464 Selenium deficiency results in increased activity of DAT protein CTD PMID:11113527 elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of DAT mRNA CTD PMID:11113527 endosulfan multiple interactions EXP 6480464 Endosulfan inhibits the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 estrone multiple interactions ISO RGD:11315 6480464 Estrone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16011487 ethanol multiple interactions ISO RGD:11315 6480464 Ethanol promotes the reaction [mephedrone results in decreased expression of SLC6A3 protein] CTD PMID:26747301 fluoxetine multiple interactions ISO RGD:11315 6480464 SLC6A3 mutant form affects the reaction [Fluoxetine affects the abundance of Dopamine] CTD PMID:14691264 fluoxetine multiple interactions ISO RGD:733809 6480464 Fluoxetine inhibits the reaction [SLC6A3 protein results in increased import of Biogenic Monoamines analog] more ... CTD PMID:28506818 , PMID:31009648 fluoxetine affects expression EXP 6480464 Fluoxetine affects the expression of SLC6A3 CTD PMID:26475043 fluoxetine affects response to substance ISO RGD:11315 6480464 SLC6A3 protein affects the susceptibility to Fluoxetine CTD PMID:11797063 ganglioside GM1 increases expression EXP 6480464 GM1 Ganglioside results in increased expression of SLC6A3 mRNA CTD PMID:14552908 geraniol multiple interactions ISO RGD:11315 6480464 geraniol inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23943375 glyburide multiple interactions ISO RGD:11315 6480464 Glyburide promotes the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:16725203 haloperidol multiple interactions ISO RGD:11315 6480464 SLC6A3 protein promotes the reaction [Haloperidol results in increased expression of NTS mRNA] CTD PMID:14698760 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of SLC6A3 protein CTD PMID:17069804 heptachlor multiple interactions ISO RGD:11315 6480464 Heptachlor promotes the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:11294980 heptachlor increases expression ISO RGD:11315 6480464 Heptachlor results in increased expression of SLC6A3 mRNA, Heptachlor results in increased expression of SLC6A3 protein CTD PMID:10499361 more ... heptachlor increases expression EXP 6480464 Heptachlor results in increased expression of SLC6A3 protein CTD PMID:11719704 herbicide decreases expression EXP 6480464 Herbicides results in decreased expression of SLC6A3 mRNA CTD PMID:23123945 ibogaine multiple interactions ISO RGD:733809 6480464 Ibogaine inhibits the reaction [SLC6A3 protein mutant form results in decreased import of Dopamine], Ibogaine promotes the reaction [SLC6A3 protein results in increased import of Dopamine] CTD PMID:27555326 ibogaine increases expression ISO RGD:733809 6480464 Ibogaine results in increased expression of SLC6A3 protein CTD PMID:27555326 ibuprofen multiple interactions ISO RGD:11315 6480464 Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] CTD PMID:18946735 iron atom multiple interactions EXP 6480464 [manganese chloride co-treated with Iron deficiency] results in decreased expression of SLC6A3 protein CTD PMID:22479410 iron(0) multiple interactions EXP 6480464 [manganese chloride co-treated with Iron deficiency] results in decreased expression of SLC6A3 protein CTD PMID:22479410 isoliquiritigenin multiple interactions ISO RGD:11315 6480464 isoliquiritigenin inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] CTD PMID:19834288 ketamine multiple interactions ISO RGD:733809 6480464 Ketamine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:31009648 linalool decreases expression EXP 6480464 linalool results in decreased expression of SLC6A3 mRNA CTD PMID:20536181 lipopolysaccharide multiple interactions ISO RGD:11315 6480464 LRRK2 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC6A3 protein] CTD PMID:32247534 lipopolysaccharide decreases expression ISO RGD:11315 6480464 Lipopolysaccharides results in decreased expression of SLC6A3 protein CTD PMID:32247534 maneb multiple interactions ISO RGD:11315 6480464 [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 mRNA, [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 protein CTD PMID:11124998 , PMID:18386188 maneb affects response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism affects the susceptibility to Maneb CTD PMID:19590691 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of SLC6A3 protein CTD PMID:16571372 manganese atom affects localization ISO RGD:733809 6480464 Manganese affects the localization of SLC6A3 protein CTD PMID:23313730 manganese atom multiple interactions ISO RGD:733809 6480464 LRRK2 mutant form results in increased susceptibility to [Manganese co-treated with SLC6A3 protein] CTD PMID:23628791 manganese atom increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to Manganese CTD PMID:18206288 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of SLC6A3 protein CTD PMID:16571372 manganese(0) affects localization ISO RGD:733809 6480464 Manganese affects the localization of SLC6A3 protein CTD PMID:23313730 manganese(0) multiple interactions ISO RGD:733809 6480464 LRRK2 mutant form results in increased susceptibility to [Manganese co-treated with SLC6A3 protein] CTD PMID:23628791 manganese(0) increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to Manganese CTD PMID:18206288 manganese(II) chloride multiple interactions EXP 6480464 [manganese chloride co-treated with Iron deficiency] results in decreased expression of SLC6A3 protein CTD PMID:22479410 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC6A3, manganese chloride results in decreased expression of SLC6A3 protein CTD PMID:16571372 more ... manganese(II) chloride decreases expression ISO RGD:11315 6480464 manganese chloride results in decreased expression of SLC6A3 protein CTD PMID:24969583 manganese(II) chloride multiple interactions ISO RGD:11315 6480464 Melatonin inhibits the reaction [manganese chloride results in decreased expression of SLC6A3 protein] CTD PMID:24969583 Mazindol affects binding ISO RGD:11315 6480464 Mazindol binds to SLC6A3 protein CTD PMID:11085313 more ... Mazindol multiple interactions EXP 6480464 Methamphetamine inhibits the reaction [Mazindol binds to SLC6A3 protein] CTD PMID:9132989 Mazindol affects binding EXP 6480464 Mazindol binds to SLC6A3 protein CTD PMID:11719704 , PMID:9132989 Mazindol multiple interactions ISO RGD:11315 6480464 Methamphetamine inhibits the reaction [Mazindol binds to SLC6A3 protein], NOS1 protein affects the reaction [Methamphetamine inhibits the reaction [Mazindol binds to SLC6A3 protein]] CTD PMID:11085313 Mazindol multiple interactions ISO RGD:733809 6480464 [Mazindol results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium more ... CTD PMID:17250655 , PMID:18206288 Mecamylamine multiple interactions EXP 6480464 Mecamylamine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein] CTD PMID:23999947 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein] CTD PMID:18289173 melatonin multiple interactions ISO RGD:11315 6480464 Melatonin inhibits the reaction [manganese chloride results in decreased expression of SLC6A3 protein] CTD PMID:24969583 melittin increases localization ISO RGD:733809 6480464 Melitten results in increased localization of SLC6A3 protein CTD PMID:20969853 , PMID:22683840 melittin multiple interactions ISO RGD:733809 6480464 Cocaine inhibits the reaction [Melitten results in increased localization of SLC6A3 protein] more ... CTD PMID:20969853 , PMID:22683840 mephedrone decreases expression EXP 6480464 mephedrone results in decreased expression of SLC6A3 protein CTD PMID:25817894 mephedrone decreases expression ISO RGD:11315 6480464 mephedrone results in decreased expression of SLC6A3 protein CTD PMID:26747301 mephedrone multiple interactions ISO RGD:11315 6480464 Ethanol promotes the reaction [mephedrone results in decreased expression of SLC6A3 protein] CTD PMID:26747301 mepyramine multiple interactions ISO RGD:733809 6480464 Pyrilamine analog binds to and affects the activity of SLC6A3 protein CTD PMID:11931612 methamphetamine increases response to substance ISO RGD:733809 6480464 SLC6A3 3' UTR polymorphism results in increased susceptibility to Methamphetamine CTD PMID:12931138 methamphetamine decreases expression ISO RGD:733809 6480464 Methamphetamine results in decreased expression of SLC6A3 protein CTD PMID:12944350 more ... methamphetamine decreases activity EXP 6480464 Methamphetamine results in decreased activity of SLC6A3 protein CTD PMID:11032899 more ... methamphetamine affects response to substance ISO RGD:11315 6480464 SLC6A3 protein affects the susceptibility to Methamphetamine CTD PMID:12050851 , PMID:20558209 methamphetamine affects abundance ISO RGD:733809 6480464 SLC6A3 protein affects the abundance of Methamphetamine CTD PMID:11027249 methamphetamine decreases activity ISO RGD:733809 6480464 Methamphetamine results in decreased activity of SLC6A3 protein CTD PMID:16842981 methamphetamine multiple interactions ISO RGD:733809 6480464 indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SLC6A3 protein CTD PMID:15900317 , PMID:19648469 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of SLC6A3 protein CTD PMID:15986185 methamphetamine multiple interactions EXP 6480464 Methamphetamine inhibits the reaction [1R-exo more ... CTD PMID:16897726 , PMID:9132989 methamphetamine decreases response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form results in decreased susceptibility to Methamphetamine CTD PMID:11222668 methamphetamine decreases expression ISO RGD:11315 6480464 Methamphetamine results in decreased expression of DAT protein more ... CTD PMID:10559418 more ... methamphetamine multiple interactions ISO RGD:11315 6480464 15-deoxyprostaglandin J2 inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] more ... CTD PMID:10559418 more ... methapyrilene increases methylation ISO RGD:733809 6480464 Methapyrilene results in increased methylation of SLC6A3 intron CTD PMID:30157460 methcathinone decreases expression ISO RGD:733809 6480464 monomethylpropion results in decreased expression of SLC6A3 protein CTD PMID:9763484 methoxychlor decreases expression ISO RGD:11315 6480464 Methoxychlor results in decreased expression of SLC6A3 protein CTD PMID:19459224 methylmercury chloride multiple interactions ISO RGD:11315 6480464 methylmercuric chloride inhibits the reaction [DAT protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:21385734 methylphenidate multiple interactions ISO RGD:733809 6480464 [Methylphenidate co-treated with SLC6A3 protein] results in increased expression of FOS protein more ... CTD PMID:12112414 more ... methylphenidate decreases expression ISO RGD:11315 6480464 Methylphenidate results in decreased expression of SLC6A3 mRNA CTD PMID:22470460 , PMID:33647392 methylphenidate decreases expression ISO RGD:733809 6480464 Methylphenidate results in decreased expression of SLC6A3 protein CTD PMID:15059031 , PMID:16139732 methylphenidate increases response to substance ISO RGD:11315 6480464 SLC6A3 protein results in increased susceptibility to Methylphenidate CTD PMID:12699766 methylphenidate multiple interactions ISO RGD:11315 6480464 SLC6A3 protein affects the reaction [Methylphenidate results in increased expression of FOS protein] CTD PMID:12699766 methylphenidate affects response to substance ISO RGD:733809 6480464 SLC6A3 3' UTR polymorphism affects the susceptibility to Methylphenidate, SLC6A3 protein polymorphism affects the susceptibility to Methylphenidate CTD PMID:19462300 , PMID:31009648 minocycline multiple interactions ISO RGD:11315 6480464 Minocycline inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein] CTD PMID:16839653 modafinil affects response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism affects the susceptibility to modafinil CTD PMID:24403155 modafinil multiple interactions EXP 6480464 modafinil inhibits the reaction [SLC6A3 protein affects the uptake of Dopamine] CTD PMID:19197004 modafinil decreases response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form results in decreased susceptibility to modafinil CTD PMID:11222668 monensin A multiple interactions ISO RGD:733809 6480464 Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]] CTD PMID:29908239 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733809 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NDFIP1 protein results in decreased expression of SLC6A3 protein] CTD PMID:26300475 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of SLC6A3 gene CTD PMID:16495775 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:733809 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [1R-exo more ... CTD PMID:12151787 more ... N-methyl-4-phenylpyridinium decreases expression ISO RGD:733809 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 protein CTD PMID:30463061 N-methyl-4-phenylpyridinium increases uptake EXP 6480464 SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:24841869 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 4-methylaminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... CTD PMID:24841869 N-methyl-4-phenylpyridinium increases expression ISO RGD:11315 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A3 mRNA CTD PMID:26558463 N-methyl-4-phenylpyridinium decreases expression ISO RGD:11315 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 protein CTD PMID:23665943 , PMID:26056851 N-methyl-4-phenylpyridinium affects binding ISO RGD:11315 6480464 1-Methyl-4-phenylpyridinium binds to SLC6A3 protein CTD PMID:23665943 N-methyl-4-phenylpyridinium increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:12151787 more ... N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A3 protein CTD PMID:19794909 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:11315 6480464 methylmercuric chloride inhibits the reaction [DAT protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:21385734 N-methyl-4-phenylpyridinium increases uptake ISO RGD:11315 6480464 DAT protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:21385734 N-methyl-4-phenylpyridinium increases response to substance EXP 6480464 SLC6A3 protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:10881039 N-methyl-4-phenylpyridinium increases uptake ISO RGD:733809 6480464 DAT protein results in increased uptake of 1-Methyl-4-phenylpyridinium, SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:17250655 more ... N-methyl-4-phenylpyridinium affects response to substance ISO RGD:733809 6480464 SLC6A3 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:12151787 naltrexone multiple interactions ISO RGD:11315 6480464 Naltrexone inhibits the reaction [Enkephalin, Leucine-2-Alanine inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]] CTD PMID:9765353 naltrexone affects response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism affects the susceptibility to Naltrexone CTD PMID:18552399 nicotine decreases expression ISO RGD:11315 6480464 Nicotine results in decreased expression of SLC6A3 mRNA, Nicotine results in decreased expression of SLC6A3 protein CTD PMID:31945395 nicotine increases methylation ISO RGD:11315 6480464 Nicotine results in increased methylation of SLC6A3 promoter CTD PMID:31945395 nicotine multiple interactions ISO RGD:11315 6480464 Nicotine inhibits the reaction [Paraquat results in decreased expression of SLC6A3 protein] CTD PMID:17227438 nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of SLC6A3 protein CTD PMID:23999947 nicotine multiple interactions EXP 6480464 Dihydro-beta-Erythroidine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein], Mecamylamine affects the reaction [Nicotine results in decreased activity of SLC6A3 protein] CTD PMID:23999947 nomifensine multiple interactions EXP 6480464 Nomifensine inhibits the reaction [Rotenone results in decreased expression of SLC6A3 protein] CTD PMID:18289173 nomifensine multiple interactions ISO RGD:733809 6480464 [Nomifensine results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium, Nomifensine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:18206288 , PMID:20875051 Nonylphenol multiple interactions EXP 6480464 nonylphenol affects the reaction [SLC6A3 protein affects the export of Dopamine] CTD PMID:19479021 octopamine multiple interactions ISO RGD:733809 6480464 indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 oleic acid multiple interactions ISO RGD:11315 6480464 PPARA protein promotes the reaction [Oleic Acid results in increased expression of SLC6A3 mRNA] CTD PMID:18489776 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of SLC6A3 mRNA CTD PMID:15303306 oxidopamine increases response to substance EXP 6480464 SLC6A3 protein results in increased susceptibility to Oxidopamine CTD PMID:10881039 oxidopamine decreases expression EXP 6480464 Oxidopamine results in decreased expression of SLC6A3 mRNA, Oxidopamine results in decreased expression of SLC6A3 protein CTD PMID:15518916 , PMID:20200117 paraquat multiple interactions ISO RGD:11315 6480464 [Paraquat co-treated with Maneb] results in decreased expression of SLC6A3 mRNA more ... CTD PMID:11124998 more ... paraquat decreases expression ISO RGD:11315 6480464 Paraquat results in decreased expression of SLC6A3 mRNA, Paraquat results in decreased expression of SLC6A3 protein CTD PMID:17227438 , PMID:20079141 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC6A3 mRNA, Paraquat results in increased expression of SLC6A3 protein CTD PMID:20553223 paraquat multiple interactions EXP 6480464 Paraquat inhibits the reaction [1-2 diphenylmethoxyethyl-4-3-phenylpropylpiperazine binds to SLC6A3 protein] more ... CTD PMID:15985715 more ... paraquat affects response to substance ISO RGD:733809 6480464 SLC6A3 gene polymorphism affects the susceptibility to Paraquat CTD PMID:19590691 permethrin affects activity ISO RGD:733809 6480464 Permethrin affects the activity of SLC6A3 protein CTD PMID:16005927 permethrin increases expression ISO RGD:11315 6480464 Permethrin results in increased expression of SLC6A3 protein CTD PMID:12428726 more ... permethrin decreases expression ISO RGD:11315 6480464 Permethrin results in decreased expression of SLC6A3 protein CTD PMID:14555407 permethrin multiple interactions ISO RGD:733809 6480464 Permethrin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:16005927 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733809 6480464 [Tretinoin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SLC6A3 protein, Tetradecanoylphorbol Acetate results in increased localization of [SLC6A3 protein co-treated with EEA1 protein] CTD PMID:22683840 , PMID:24101030 piperazines multiple interactions ISO RGD:733809 6480464 Piperazines analog binds to and affects the activity of SLC6A3 protein CTD PMID:11931612 piperidines affects binding ISO RGD:733809 6480464 Piperidines analog binds to SLC6A3 protein CTD PMID:12413863 pirinixic acid multiple interactions ISO RGD:733809 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC6A3 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:11315 6480464 pirinixic acid results in increased expression of SLC6A3 mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC6A3 mRNA CTD PMID:19162173 probenecid multiple interactions ISO RGD:11315 6480464 1 more ... CTD PMID:19653878 more ... propofol decreases expression ISO RGD:11315 6480464 Propofol results in decreased expression of SLC6A3 protein CTD PMID:32612007 quinolinic acid decreases expression EXP 6480464 Quinolinic Acid results in decreased expression of SLC6A3 protein CTD PMID:12207953 quinolinic acid increases expression EXP 6480464 Quinolinic Acid results in increased expression of SLC6A3 protein CTD PMID:12207953 quinpirole affects localization ISO RGD:733809 6480464 Quinpirole affects the localization of SLC6A3 protein CTD PMID:20875051 quinpirole increases expression EXP 6480464 Quinpirole results in increased expression of SLC6A3 mRNA CTD PMID:20875051 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of SLC6A3 protein CTD PMID:16451217 reboxetine affects response to substance ISO RGD:11315 6480464 SLC6A3 protein affects the susceptibility to reboxetine CTD PMID:11312315 reserpine decreases activity ISO RGD:11315 6480464 Reserpine results in decreased activity of SLC6A3 protein CTD PMID:17664021 reserpine affects response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form affects the susceptibility to Reserpine CTD PMID:19615345 rotenone multiple interactions EXP 6480464 lipopolysaccharide more ... CTD PMID:18289173 , PMID:23567316 rotenone decreases expression ISO RGD:733809 6480464 Rotenone results in decreased expression of SLC6A3 mRNA CTD PMID:29955902 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC6A3 protein CTD PMID:18579341 , PMID:23567316 rotenone increases response to substance ISO RGD:733809 6480464 SLC6A3 protein results in increased susceptibility to Rotenone CTD PMID:18206288 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC6A3 protein CTD PMID:18289173 rottlerin multiple interactions ISO RGD:11315 6480464 [rottlerin results in decreased activity of PRKCD protein] inhibits the reaction [Methamphetamine results in decreased expression of DAT protein] CTD PMID:22512859 SCH 23390 multiple interactions ISO RGD:11315 6480464 SCH 23390 inhibits the reaction [1-2-thienyl-2-methylaminopropane results in decreased expression of SLC6A3 protein] CTD PMID:30922767 selenium atom increases activity EXP 6480464 Selenium deficiency results in increased activity of DAT protein CTD PMID:11113527 selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of DAT mRNA CTD PMID:11113527 serotonin multiple interactions ISO RGD:733809 6480464 SLC6A3 protein promotes the reaction [Serotonin results in increased activity of TAAR1 protein] CTD PMID:17234900 serotonin increases uptake ISO RGD:733809 6480464 SLC6A3 protein results in increased uptake of Serotonin CTD PMID:17250655 simazine affects expression ISO RGD:11315 6480464 Simazine affects the expression of SLC6A3 mRNA, Simazine affects the expression of SLC6A3 protein CTD PMID:29137186 simazine decreases expression EXP 6480464 Simazine results in decreased expression of SLC6A3 mRNA, Simazine results in decreased expression of SLC6A3 protein CTD PMID:29115391 staurosporine multiple interactions ISO RGD:733809 6480464 SNCA protein affects the reaction [Staurosporine results in increased activity of SLC6A3 protein] CTD PMID:19032594 staurosporine increases activity ISO RGD:733809 6480464 Staurosporine results in increased activity of SLC6A3 protein CTD PMID:19032594 sulpiride multiple interactions ISO RGD:733809 6480464 Sulpiride inhibits the reaction [Dopamine affects the localization of SLC6A3 protein], Sulpiride inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:20875051 sulpiride multiple interactions ISO RGD:11315 6480464 Sulpiride inhibits the reaction [1-2-thienyl-2-methylaminopropane results in decreased expression of SLC6A3 protein] CTD PMID:30922767 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC6A3 protein CTD PMID:16451217 telmisartan multiple interactions ISO RGD:11315 6480464 telmisartan inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23747572 testosterone multiple interactions ISO RGD:733809 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SLC6A3 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:733809 6480464 Testosterone results in increased expression of SLC6A3 mRNA CTD PMID:21592394 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SLC6A3 mRNA CTD PMID:17805973 titanium dioxide decreases expression ISO RGD:11315 6480464 titanium dioxide results in decreased expression of SLC6A3 mRNA CTD PMID:29264374 titanium dioxide multiple interactions ISO RGD:11315 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A3 mRNA CTD PMID:29950665 toluene affects expression EXP 6480464 Toluene affects the expression of SLC6A3 mRNA CTD PMID:18653662 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of SLC6A3 mRNA CTD PMID:28743636 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of SLC6A3 mRNA CTD PMID:33078273 tryptamine multiple interactions ISO RGD:733809 6480464 indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 tyramine multiple interactions ISO RGD:733809 6480464 indatraline inhibits the reaction [SLC6A3 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 valproic acid multiple interactions EXP 6480464 Valproic Acid promotes the reaction [NR4A2 protein binds to SLC6A3 promoter] CTD PMID:28743636 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC6A3 mRNA, Valproic Acid results in increased expression of SLC6A3 protein CTD PMID:28743636 valproic acid increases methylation ISO RGD:733809 6480464 Valproic Acid results in increased methylation of SLC6A3 gene CTD PMID:29154799 vanoxerine dihydrochloride affects binding ISO RGD:733809 6480464 vanoxerine binds to SLC6A3 protein CTD PMID:11249581 vanoxerine dihydrochloride decreases response to substance ISO RGD:11315 6480464 SLC6A3 gene mutant form results in decreased susceptibility to vanoxerine CTD PMID:11222668 vanoxerine dihydrochloride multiple interactions ISO RGD:11315 6480464 vanoxerine inhibits the reaction [SLC6A3 protein promotes the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:22342763 vanoxerine dihydrochloride multiple interactions EXP 6480464 vanoxerine affects the reaction [Cocaine affects the expression of SLC6A3 protein] CTD PMID:11249581 vanoxerine dihydrochloride decreases activity ISO RGD:11315 6480464 vanoxerine results in decreased activity of SLC6A3 protein CTD PMID:19616025 , PMID:22342763 vanoxerine dihydrochloride decreases activity EXP 6480464 vanoxerine results in decreased activity of SLC6A3 protein CTD PMID:18561912 vanoxerine dihydrochloride affects response to substance ISO RGD:11315 6480464 SLC6A3 protein affects the susceptibility to vanoxerine CTD PMID:11312315 vanoxerine dihydrochloride multiple interactions ISO RGD:733809 6480464 [vanoxerine results in decreased activity of SLC6A3 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium, vanoxerine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:17250655 , PMID:18206288 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of SLC6A3 gene CTD PMID:31079544 vorinostat increases expression ISO RGD:733809 6480464 vorinostat results in increased expression of SLC6A3 mRNA CTD PMID:27188386 WIN 55212-2 multiple interactions EXP 6480464 AM 251 affects the reaction [3R-2 more ... CTD PMID:29113897 WIN 55212-2 affects expression EXP 6480464 3R-2 more ... CTD PMID:29113897 wortmannin multiple interactions ISO RGD:733809 6480464 wortmannin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] CTD PMID:20875051 zinc atom multiple interactions ISO RGD:733809 6480464 [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein CTD PMID:16684900 zinc atom decreases activity ISO RGD:733809 6480464 Zinc results in decreased activity of SLC6A3 protein CTD PMID:16684900 zinc sulfate multiple interactions EXP 6480464 Paraquat promotes the reaction [Zinc Sulfate results in increased expression of SLC6A3 mRNA] more ... CTD PMID:20553223 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of SLC6A3 mRNA, Zinc Sulfate results in increased expression of SLC6A3 protein CTD PMID:20553223 zinc(0) multiple interactions ISO RGD:733809 6480464 [Amphetamine co-treated with Zinc] results in decreased localization of SLC6A3 protein CTD PMID:16684900 zinc(0) decreases activity ISO RGD:733809 6480464 Zinc results in decreased activity of SLC6A3 protein CTD PMID:16684900
